320 related articles for article (PubMed ID: 17853916)
21. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Perdoni C; Osborn MJ; Tolar J
Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
[TBL] [Abstract][Full Text] [Related]
22. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
Chung HJ; Uitto J
Dermatol Clin; 2010 Jan; 28(1):93-105. PubMed ID: 19945621
[TBL] [Abstract][Full Text] [Related]
23. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
24. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
[TBL] [Abstract][Full Text] [Related]
25. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
[No Abstract] [Full Text] [Related]
26. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
Dayal JH; Cole CL; Pourreyron C; Watt SA; Lim YZ; Salas-Alanis JC; Murrell DF; McGrath JA; Stieger B; Jahoda C; Leigh IM; South AP
J Cell Sci; 2014 Feb; 127(Pt 4):740-51. PubMed ID: 24357722
[TBL] [Abstract][Full Text] [Related]
27. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
28. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
[TBL] [Abstract][Full Text] [Related]
29. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development.
Guerra L; Odorisio T; Zambruno G; Castiglia D
Matrix Biol; 2017 Nov; 63():1-10. PubMed ID: 28126522
[TBL] [Abstract][Full Text] [Related]
30. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
[No Abstract] [Full Text] [Related]
31. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
[TBL] [Abstract][Full Text] [Related]
32. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
33. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
[TBL] [Abstract][Full Text] [Related]
34. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
[TBL] [Abstract][Full Text] [Related]
35. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
Dang N; Klingberg S; Marr P; Murrell DF
J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
[TBL] [Abstract][Full Text] [Related]
36. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa.
Vincent C; Lefort N; Hamlin M; Banal C; Hovnanian A; Izmiryan A
Stem Cell Res; 2023 Jun; 69():103104. PubMed ID: 37148821
[TBL] [Abstract][Full Text] [Related]
38. A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
Windler C; Hermsdorf U; Brinckmann J; Seeger K
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):52-59. PubMed ID: 27989960
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
[TBL] [Abstract][Full Text] [Related]
40. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]